Search

Your search keyword '"Dondorp Arjen M"' showing total 2,056 results

Search Constraints

Start Over You searched for: Author "Dondorp Arjen M" Remove constraint Author: "Dondorp Arjen M"
2,056 results on '"Dondorp Arjen M"'

Search Results

1. Genome-wide microsatellite characteristics of five human Plasmodium species, focusing on Plasmodium malariae and P. ovale curtisi

4. A randomised trial of malaria vaccine R21/Matrix-M™ with and without antimalarial drugs in Thai adults

5. Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial

6. Expanding the roles of community health workers to sustain programmes during malaria elimination: a meeting report on operational research in Southeast Asia

8. CONTRIBUTORS

9. Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV)

10. Primaquine for uncomplicated Plasmodium vivax malaria in children younger than 15 years: a systematic review and individual patient data meta-analysis

11. Retinopathy and microcirculation in adult severe malaria

13. Different ventilation intensities among various categories of patients ventilated for reasons other than ARDS––A pooled analysis of 4 observational studies

14. Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms

21. Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis

22. Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis

23. Clustering of malaria in households in the Greater Mekong Subregion: operational implications for reactive case detection

24. Genetic surveillance in the Greater Mekong subregion and South Asia to support malaria control and elimination.

25. Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial

28. Temporal trends in severe malaria in Chittagong, Bangladesh

29. Sequence variation does not confound the measurement of plasma PfHRP2 concentration in African children presenting with severe malaria

30. The effects of serum lipids on the in vitro activity of lumefantrine and atovaquone against Plasmodium falciparum

31. Central venous catheter use in severe malaria: time to reconsider the World Health Organization guidelines?

32. Decreasing incidence of severe malaria and community-acquired bacteraemia among hospitalized children in Muheza, north-eastern Tanzania, 2006-2010

33. Coma in fatal adult human malaria is not caused by cerebral oedema

34. Laboratory prediction of the requirement for renal replacement in acute falciparum malaria

35. Artemisinin resistance in Plasmodium falciparum is associated with an altered temporal pattern of transcription

36. Modelling malaria elimination on the internet

37. Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum

38. Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial

39. Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance

40. FlexiChip package: an universal microarray with a dedicated analysis software for high-thoughput SNPs detection linked to anti-malarial drug resistance

41. The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia

42. Pharmacokinetics of single low dose primaquine in Ugandan and Congolese children with falciparum malaria

43. Spread of anti-malarial drug resistance: Mathematical model with implications for ACT drug policies

44. Malaria outbreak in Laos driven by a selective sweep for Plasmodium falciparum kelch13 R539T mutants: a genetic epidemiology analysis

45. Mass drug administrations with dihydroartemisinin-piperaquine and single low dose primaquine to eliminate Plasmodium falciparum have only a transient impact on Plasmodium vivax: Findings from randomised controlled trials

47. Treatment-seeking behaviour for febrile illnesses and its implications for malaria control and elimination in Savannakhet Province, Lao PDR (Laos): a mixed method study

49. Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trial

50. Genetic surveillance ofPlasmodium falciparumreveals rapid population changes following first-line treatment policy revisions in the Greater Mekong Subregion

Catalog

Books, media, physical & digital resources